Evidence map›Paper›PMID 33888076›Full record

ArticleBMC public health2021

Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families.

John Charles A Lacson, Shawn A Zamani, Luis Alberto Ribeiro Froes, Nandita Mitra, Lu Qian, Scarlet H Doyle, Esther Azizi, Claudia Balestrini, D Timothy Bishop, William Bruno and 29 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Article
  3. The effects of exposure to solar radiation on human health.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors at 20 institutions in 15 countries.

John Charles A Lacson *Department of Cancer Epidemiology, Division of Population Science, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Dr., MRC 213, Tampa, FL, 33612, USA.
Shawn A Zamani *Department of Cancer Epidemiology, Division of Population Science, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Dr., MRC 213, Tampa, FL, 33612, USA.
Luis Alberto Ribeiro FroesDepartment of Pathology, School of Medicine, Universidade de São Paulo (USP), São Paulo, SP, Brazil.ORCID 0000-0002-1140-3046
Nandita MitraDepartment of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA.
Lu QianSWOG Statistics and Data Management Center, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Scarlet H DoyleDepartment of Cancer Epidemiology, Division of Population Science, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Dr., MRC 213, Tampa, FL, 33612, USA.
Esther AziziDepartment of Dermatology, Sheba Medical Center, Tel Hashomer, Israel.
Claudia BalestriniServicio de Dermatología, Hospital Dr. Sótero del Río, Santiago de Chile, Chile.
D Timothy BishopInstitute of Medical Research at St James's, University of Leeds, Leeds, UK.
William BrunoDepartment of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.
Blanca Carlos-OrtegaDepartamento de Ciencias Básicas, Escuela de Medicina Universidad de Monterrey, Monterrey, Mexico.
Francisco CuellarMelanoma Unit, Dermatology Department, Hospital Clinic Barcelona, Institut de Investigacions biomediques August Pi Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
Anne E CustSydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
David E ElderDepartment of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Anne-Marie GerdesDepartment of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark.
Paola GhiorzoDepartment of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.
Thais C GrazziotinPontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.
Nelleke A GruisDepartment of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands.
Johan HanssonDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Marko HočevarInstitute of Oncology Ljubljana, Ljubljana, Slovenia.
Veronica HöiomDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Elizabeth A HollandWestmead Institute for Medical Research, The University of Sydney, Westmead, New South Wales, Australia.
Christian IngvarDepartments of Clinical Sciences and Surgery, Lund University Hospital, Lund, Sweden.
Gilles LandmanDepartment of Pathology, Escola Paulista de Medicina, UNIFESP, São Paulo, Brazil.
Alejandra Larre-BorgesUnidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay.
Graham J MannMelanoma Institute Australia, The University of Sydney, Wollstonecraft, New South Wales, Australia.
Montserrat MolgoPontificia Universidad Católica de Chile, Santiago de Chile, Chile.
Luciana Facure MoredoSkin Cancer Department, AC Camargo Cancer Center, São Paulo, Brazil.
Håkan OlssonDepartments of Clinical Sciences and Surgery, Lund University Hospital, Lund, Sweden.
Jacoba J Out-LuitingDepartment of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands.
Barbara PerićInstitute of Oncology Ljubljana, Ljubljana, Slovenia.
Dace PjanovaLatvian Biomedical Research and Study Centre, Riga, Latvia.
Susana PuigMelanoma Unit, Dermatology Department, Hospital Clinic Barcelona, Institut de Investigacions biomediques August Pi Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
Julio Salas-AlanisDepartamento de Ciencias Básicas, Escuela de Medicina Universidad de Monterrey, Monterrey, Mexico.
Helen SchmidWestmead Institute for Medical Research, The University of Sydney, Westmead, New South Wales, Australia.
Karin A W WadtDepartment of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark.
Julia A Newton-BishopInstitute of Medical Research at St James's, University of Leeds, Leeds, UK.
Peter A KanetskyDepartment of Cancer Epidemiology, Division of Population Science, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Dr., MRC 213, Tampa, FL, 33612, USA. Peter.Kanetsky@moffitt.org.ORCID 0000-0002-5567-9618
GenoMEL Study Group
The University of Sydney · AUMoffitt Cancer Center · USUniversity of Leeds · GBLeiden University Medical Center · NLLund University · SEKarolinska Institutet · SELatvian Biomedical Research and Study Centre · LVUniversidade de São Paulo · BRAustralian National University · AUConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESCopenhagen University Hospital · DKFred Hutch Cancer Center · USHospital of the University of Pennsylvania · USInstituto de Salud Carlos III · ESOspedale Policlinico San Martino · ITPontificia Universidad Católica de Chile · CLSheba Medical Center · ILTel Aviv University · ILUniversidad de la República de Uruguay · UYUniversity of Genoa · IT

Funding

Genetic Epidermiology of MelanomaR01CA083115 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BISHOP, DAVID TIMOTHY, ELDER, DAVID ERIC · 2001 to 2017
$13.0M
Cancer Research UK 19167NCI NIH HHS R01 CA083115NIH HHS R01 CA83115
6 · The paper itself

Abstract

backgroundIndividuals from melanoma-prone families have similar or reduced sun-protective behaviors compared to the general population. Studies on trends in sun-related behaviors have been temporally and geographically limited.

methodsIndividuals from an international consortium of melanoma-prone families (GenoMEL) were retrospectively asked about sunscreen use, sun exposure (time spent outside), sunburns, and sunbed use at several timepoints over their lifetime. Generalized linear mixed models were used to examine the association between these outcomes and birth cohort defined by decade spans, after adjusting for covariates.

resultsA total of 2407 participants from 547 families across 17 centers were analyzed. Sunscreen use increased across subsequent birth cohorts, and although the likelihood of sunburns increased until the 1950s birth cohort, it decreased thereafter. Average sun exposure did not change across the birth cohorts, and the likelihood of sunbed use increased in more recent birth cohorts. We generally did not find any differences in sun-related behavior when comparing melanoma cases to non-cases. Melanoma cases had increased sunscreen use, decreased sun exposure, and decreased odds of sunburn and sunbed use after melanoma diagnosis compared to before diagnosis.

conclusionsAlthough sunscreen use has increased and the likelihood of sunburns has decreased in more recent birth cohorts, individuals in melanoma-prone families have not reduced their overall sun exposure and had an increased likelihood of sunbed use in more recent birth cohorts. These observations demonstrate partial improvements in melanoma prevention and suggest that additional intervention strategies may be needed to achieve optimal sun-protective behavior in melanoma-prone families.

Indexed as

MelanomaSkin NeoplasmsSunburnHumansRetrospective StudiesSunscreening AgentsSunscreening AgentsHigh-risk familiesMelanomaSkin CancerSunbedSunburnSun exposureSun-related behaviorsSunscreen useTrends

Identifiers

PMID33888076
PMCPMC8063451
OpenAlexW3153345380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.